Actinium Pharmaceuticals, Inc. (ATNM) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Listing Notice, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-18 | 8-K | Other Events | SEC |
| 2026-05-29 | 8-K | Listing Notice, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-13 | 8-K | Officer / Director Changes | SEC |
| 2025-11-26 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2025-05-09 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-11-27 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2024-11-05 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.